Login
$JBDI
$2.41 +$0.01 (0.42%) Close

Consolidated Balance Sheets

In USD, except per-share amounts
Q4 FY2026
As of May 31, 2026
Q4 FY2025
As of May 31, 2025
Q4 FY2024
As of May 31, 2024
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Deposits, prepayments and other receivables
Total current assets
Non-current assets:
Property and equipment, net
Right-of-use assets
Total non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accounts payable and accrued liabilities
Amounts due to related parties
Bank borrowings
Current liabilities
Income tax payable
Total current liabilities
Long-term liability
Lease liabilities
Total long-term liability
TOTAL LIABILITIES
Shareholders’ equity
Ordinary Shares, par value US$0.001, 500,000,000 Ordinary Shares authorized, 9,893,750 Ordinary Shares issued and 9,514,532 outstanding as of May 31, 2026; 9,627,236 outstanding as of May 31, 2025
Additional paid-in capital
Treasury shares, at cost: 379,218 and 266,515, respectively
Capital reserves
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support